Insider Holders & Insider Ownership - Monte Rosa Therapeutics Inc. (GLUE)

List of insiders holdings for Monte Rosa Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
New Enterprise Associates 17 L.P.
NEA Partners 17 L.P.
NEA 17 GP LLC
10% Owner
2021-07-12 15:49:277,694,916
0
7,694,916Form 13D
BASKETT FOREST
10% Owner
2021-06-30 18:00:440
7,692,298
7,692,298Form 4
Chang Carmen
10% Owner
2021-06-30 18:02:050
7,692,298
7,692,298Form 4
Florence Anthony A. Jr.
10% Owner
2021-06-30 18:02:570
7,692,298
7,692,298Form 4
Landsman Liza
10% Owner
2021-06-30 18:04:060
7,692,298
7,692,298Form 4
Makhzoumi Mohamad
10% Owner
2021-06-30 18:05:030
7,692,298
7,692,298Form 4
MAKOWER JOSHUA
10% Owner
2021-06-30 18:06:190
7,692,298
7,692,298Form 4
Mathers Edward T
10% Owner
2021-06-30 18:06:590
7,692,298
7,692,298Form 4
SANDELL SCOTT D
10% Owner
2021-06-30 18:07:340
7,692,298
7,692,298Form 4
Sonsini Peter W.
10% Owner
2021-06-30 18:08:180
7,692,298
7,692,298Form 4
Walker Paul Edward
10% Owner
2021-06-30 18:08:500
7,692,298
7,692,298Form 4
Yang Rick
10% Owner
2021-06-30 18:09:390
7,692,298
7,692,298Form 4
Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
2023-11-09 17:26:586,799,115
0
6,799,115Form 13D
Bolzon Bradley J PhD
Director
10% Owner
2021-06-30 17:05:140
2,097,938
2,097,938Form 4
Warmuth Markus
President & CEO
2024-01-04 16:15:42346,000
0
346,000Form 4
Tamboli Ajim
Chief Financial Officer
2023-01-04 16:30:41129,850
0
129,850Form 4
Janku Filip
Chief Medical Officer
2024-01-04 16:15:21126,252
0
126,252Form 4
Wallace Owen B.
Chief Scientific Officer
2024-01-04 16:15:41124,266
0
124,266Form 4
Nickson Philip
General Counsel
2024-01-04 16:15:18109,000
0
109,000Form 4
Jones Jullian G
Chief Business Officer
2024-01-04 16:15:2879,000
0
79,000Form 4
Townson Sharon
Chief Technology Officer
2023-01-04 16:31:0278,550
0
78,550Form 4
Castle John C.
Chief Data Scientist
2023-01-04 16:30:5778,500
0
78,500Form 4
Dunn Edmund
Principal Accounting Officer
2024-01-04 16:15:1860,900
0
60,900Form 4
Leo Chandra P.
Director
2021-06-25 17:01:1547,132
0
47,132Form 4
Manning Anthony M.
Director
2023-07-26 16:10:1541,000
0
41,000Form 4
Blackwell Kimberly
Director
2023-06-15 16:26:5420,500
0
20,500Form 4
Mayweg Alexander
Director
2023-06-15 16:27:2420,500
0
20,500Form 4
SCHIFF ANDREW N
Director
2023-06-15 16:28:3120,500
0
20,500Form 4
Siu Christine
Director
2023-06-15 16:28:5020,500
0
20,500Form 4
Skvarka Jan
Director
2023-06-15 16:29:1920,500
0
20,500Form 4
Behbahani Ali
Director
10% Owner
2023-06-15 16:42:1820,500
0
20,500Form 4
Cormorant Asset Management LP
Chen Bihua
Cormorant Global Healthcare Master Fund LP
Cormorant Private Healthcare Fund III LP
Cormorant Private Healthcare Fund II LP
Former 10% Owner
2024-02-14 15:02:410
0
0Form 13G